144 related articles for article (PubMed ID: 15912394)
1. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.
Pihlajamäki J; Kinnunen M; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kuulasmaa T; Kainulainen S; Laakso M
Diabetologia; 2005 Jul; 48(7):1331-4. PubMed ID: 15912394
[TBL] [Abstract][Full Text] [Related]
2. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
[TBL] [Abstract][Full Text] [Related]
3. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI.
Povel CM; Feskens EJ; Imholz S; Blaak EE; Boer JM; Dollé ME
Int J Obes (Lond); 2010 May; 34(5):840-5. PubMed ID: 20125101
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma coactivator 1 alpha promoter polymorphisms are associated with early-onset type 2 diabetes mellitus in the Korean population.
Kim JH; Shin HD; Park BL; Cho YM; Kim SY; Lee HK; Park KS
Diabetologia; 2005 Jul; 48(7):1323-30. PubMed ID: 15937669
[TBL] [Abstract][Full Text] [Related]
5. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
Yang Y; Mo X; Chen S; Lu X; Gu D
Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
[TBL] [Abstract][Full Text] [Related]
6. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
Su Y; Peng SB; Li ZQ; Huang QY
Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
[TBL] [Abstract][Full Text] [Related]
8. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study.
Lai CQ; Tucker KL; Parnell LD; Adiconis X; García-Bailo B; Griffith J; Meydani M; Ordovás JM
Diabetes; 2008 Apr; 57(4):809-16. PubMed ID: 18162502
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians.
Vimaleswaran KS; Radha V; Anjana M; Deepa R; Ghosh S; Majumder PP; Rao MR; Mohan V
Int J Obes (Lond); 2006 Jun; 30(6):884-91. PubMed ID: 16446747
[TBL] [Abstract][Full Text] [Related]
10. Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes.
Oberkofler H; Linnemayr V; Weitgasser R; Klein K; Xie M; Iglseder B; Krempler F; Paulweber B; Patsch W
Diabetes; 2004 May; 53(5):1385-93. PubMed ID: 15111510
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
Ling C; Del Guerra S; Lupi R; Rönn T; Granhall C; Luthman H; Masiello P; Marchetti P; Groop L; Del Prato S
Diabetologia; 2008 Apr; 51(4):615-22. PubMed ID: 18270681
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
[TBL] [Abstract][Full Text] [Related]
13. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
[TBL] [Abstract][Full Text] [Related]
15. Testing the thrifty gene hypothesis: the Gly482Ser variant in PPARGC1A is associated with BMI in Tongans.
Myles S; Lea RA; Ohashi J; Chambers GK; Weiss JG; Hardouin E; Engelken J; Macartney-Coxson DP; Eccles DA; Naka I; Kimura R; Inaoka T; Matsumura Y; Stoneking M
BMC Med Genet; 2011 Jan; 12():10. PubMed ID: 21244673
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids.
Hoeks J; Hesselink MK; Russell AP; Mensink M; Saris WH; Mensink RP; Schrauwen P
Diabetologia; 2006 Oct; 49(10):2419-26. PubMed ID: 16896940
[TBL] [Abstract][Full Text] [Related]
17. Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41).
Gayathri SB; Radha V; Vimaleswaran KS; Mohan V
Metab Syndr Relat Disord; 2010 Apr; 8(2):119-26. PubMed ID: 19900151
[TBL] [Abstract][Full Text] [Related]
18. Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner.
Brøns C; Jacobsen S; Nilsson E; Rönn T; Jensen CB; Storgaard H; Poulsen P; Groop L; Ling C; Astrup A; Vaag A
J Clin Endocrinol Metab; 2010 Jun; 95(6):3048-56. PubMed ID: 20410232
[TBL] [Abstract][Full Text] [Related]
19. Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?
Gillberg L; Jacobsen SC; Ribel-Madsen R; Gjesing AP; Boesgaard TW; Ling C; Pedersen O; Hansen T; Vaag A
PLoS One; 2013; 8(3):e58384. PubMed ID: 23505498
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetes.
Larsen LH; Rose CS; Sparsø T; Overgaard J; Torekov SS; Grarup N; Jensen DP; Albrechtsen A; Andersen G; Ek J; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Int J Obes (Lond); 2007 Feb; 31(2):365-70. PubMed ID: 16755280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
